Abstract
Background
Recurrent miscarriage (RM) or recurrent pregnancy loss (RPL) is a complex situation, characterized by two, three, or more pregnancy losses. The normal progression of pregnancy relies heavily on the proper functioning of the PROZ and ARNT genes, and their partial or complete deficiencies will result in early pregnancy loss and also recurrent pregnancy losses.
Methods
Present study aims to find PROZ and ARNT novel mutations as causes of RPL; and involves two couples that had a consanguineous marriage and were referred with three recurring miscarriages. Pathological tests were requested for the fetus, and high-resolution Giemsa banding karyotypes were requested for the couple to determine the cause. Abortion samples were also used for array CGH and whole-exome sequencing to analyze mutations. Confirming the mutation involved conducting Sanger sequencing, which is noteworthy.
Results
Based on the results, our first proband has a novel likely pathogenic homozygous mutation NM_003891:c.349T > C (p.Y117H) in the PROZ gene located on 13q34 as a novel mutation of the PROZ gene, and our second proband has a novel likely pathogenic homozygous mutation NM_001286035:exon16:c.1353-2A > G in the ARNT gene, located on 1q21.3. Sanger sequencing confirmed homozygosity of these two mutations in the probands and heterozygosity of these loci in their parents, suggesting them as likely pathogenic mutations and an autosomal recessive inheritance pattern in RPL.
Conclusion
Novel likely pathogenic homozygous mutation NM_003891:c.349T > C (p.Y117H) in PROZ gene, and novel likely pathogenic homozygous mutation in ARNT gene may be related to RPL.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tehran University of Medical Sciences, Department of Medical Genetics, School of Medicine, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
2 University of Guilan, Department of Biology, Faculty of Sciences, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250)
3 Isfahan University of Medical Sciences, Cellular, Molecular and Genetics Research Center, Isfahan, Iran (GRID:grid.411036.1) (ISNI:0000 0001 1498 685X)
4 University of Sistan and Baluchestan, Department of Biology, Faculty of Science, Zahedan, Iran (GRID:grid.412796.f) (ISNI:0000 0004 0612 766X)





